The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors

A series of competitive, reversible cathepsin S (CatS) inhibitors was investigated. An earlier disclosure detailed the discovery of the 4-(2-keto-1-benzimidazolinyl)-piperidin-1-yl moiety as an effective replacement for the 4-arylpiperazin-1-yl group found in our screening hit. Continued investigation into replacements for the 4-aryl piperazine resulted in the identification of potentially useful CatS inhibitors with enzymatic and cellular activity similar to that of JNJ 10329670 as disclosed in a previous publication.

Graphical abstractNoncovalent, potent, and selective inhibitors of the cysteine protease cathepsin S are reported.Figure optionsDownload full-size imageDownload as PowerPoint slide